NAGLAZYME (Page 5 of 5)
Packaging Components
NDC 68135-020-01
Naglazyme®
(GALSULFASE)
5 mg/5 mL (1 mg/mL)
Concentrated Solution For Intravenous Infusion Only
Must be diluted prior to use.
Rx Only
Naglazyme Carton
| NAGLAZYME galsulfase solution | |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| Labeler — BioMarin Pharmaceutical Inc. (079722386) |
Revised: 04/2020 BioMarin Pharmaceutical Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.